Enhancing Physical Activity and Healthy Aging Among Recent Retirees (REACT)

June 26, 2020 updated by: Tuija Leskinen, University of Turku

Enhancing Physical Activity and Healthy Aging Among Recent Retirees - Randomized Controlled In-home Physical Activity Trial

The purpose of REACT project is to provide cost-effective way to promote physical activity and reduce sedentary time among older adults. This is done by examining the efficacy of activity tracker based intervention on wake-time physical activity, sedentary time, sleep and other health outcomes among recent retirees. REACT study will be the first randomized physical activity trial targeted to time window right after retirement.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

231

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Finland
      • Turku, Finland, 20520
        • University of Turku /Department of Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • actual retirement date between Jan 2017 and Dec 2018
  • maximum of 12 months from the actual retirement
  • capable of doing exercise (able to walk 500 m continuously)
  • basic knowledge on how to use computer and Internet access at home

Exclusion Criteria:

  • current post-operative state or upcoming surgery within the next 6 months
  • malign cancer or recent myocardial infraction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Activity trackers
The participants were requested to wear a commercial wrist-worn activity tracker (Polar Loop 2, Polar, Kempele, Finland) every day and night for 12 months.
Device: Polar Loop 2 activity tracker
The participants were instructed to aim to reach the daily activity goal, initially set at stage 1 as per the goals set by the trackers' manufacturer. The daily activity goal was based on user's typical daily activities, gender and age. The stage 1 daily activity goal corresponded to ~1h/day of jogging or ~2h/day of walking or ~7h/day household activities or a combination of these activities. The tracker gave an inactivity alert as a vibration and text "it's time to move" on the screen of the tracker if the user has been still for 55 minutes.
No Intervention: No activity trackers
Control group members were requested to abstain from the use of any type of activity trackers and they were informed that they will receive the activity trackers and guidance for using them after the follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in wake time physical activity
Time Frame: Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.
Accelerometer based measurement
Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in wake time sedentary activity
Time Frame: Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.
Accelerometer based measurement
Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.
Change in sleep duration and quality
Time Frame: Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.
Accelerometer based measurement
Primarily change from baseline to 12 months, secondarily change from baseline to 3 months and to 6 months.
Change in metabolic profile
Time Frame: Baseline to 12 months
Fasting blood sample: lipid profile (total cholesterol, HDL, LDL, triglycerides), fasting plasma glucose, HbA1C, and CRP; blood pressure: systolic and diastolic blood pressure; body composition: fat mass, fat free mass, body weight, waist circumference
Baseline to 12 months
Change in activity locations
Time Frame: Baseline to 12 months
GPS-tracking provides data of the latitude, longitude, and time, i.e. when and where an individual is located.
Baseline to 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self-reported health
Time Frame: Baseline to 12 months
Range 1 to 5 "good to poor"
Baseline to 12 months
Change in self-reported functioning
Time Frame: Baseline to 12 months
SF-36 physical functioning, 10 items, subscale range 1 to 3 "health limits a lot to health does not limit at all", total score range 0 to 10 "no to severe limitations"
Baseline to 12 months
Change in self-reported well-being
Time Frame: Baseline to 12 months
GHQ-12, total score range 0 to 12 points, ≥4 points indicates of psychological distress
Baseline to 12 months
Change in diet
Time Frame: Baseline to 12 months
Index of Diet Quality (IDQ) score, total score range 0 to 15 points, ≥10 points indicates of healthy diet
Baseline to 12 months
Change in self-reported exercise motivation
Time Frame: Baseline to 12 months
Short version of Recreational Exercise Motivation Measure (REMM), subscale range 1 to 5 "strongly disagree to strongly agree"
Baseline to 12 months
Change in sleep difficulties
Time Frame: Baseline to 12 months
Jenkins sleep problem scale, subscale range 1 to 6 "not at all to almost every night"
Baseline to 12 months
Change in physical activity social support
Time Frame: Baseline to 12 months
Modified Social Support for Exercise Scale, subscale range 1 to 3 "never to often", mean score 1 to 3 "low to high"
Baseline to 12 months
Change in measured functioning
Time Frame: Baseline to 12 months
Number of chair test repetitions
Baseline to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Turku

Collaborators

Academy of Finland
Juho Vainio Foundation
Ministry of Education and Culture, Finland

Investigators

  • Principal Investigator: Sari Stenholm, Prof, University of Turku
  • Principal Investigator: Tuija Leskinen, Dr, University of Turku

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2018

Primary Completion (Actual)

March 1, 2020

Study Completion (Actual)

March 1, 2020

Study Registration Dates

First Submitted

October 11, 2017

First Submitted That Met QC Criteria

October 20, 2017

First Posted (Actual)

October 25, 2017

Study Record Updates

Last Update Posted (Actual)

June 30, 2020

Last Update Submitted That Met QC Criteria

June 26, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 309526

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymized partial datasets of the REACT trial are available by application with bona fide researchers with an established scientific record and bona fide organizations.

IPD Sharing Time Frame

2020-2030

IPD Sharing Access Criteria

Anonymized partial datasets of the REACT trial are available by application with bona fide researchers with an established scientific record and bona fide organizations.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Exercise

Clinical Trials on Polar Loop 2 activity tracker

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe